Psoriasis-topoproteome under ustekinumab treatment (PIROUETTE-Study) - as an interventional observation study (phase IV) within approved label and indication and with minimal invasive taking of skin biopsies - as an investigator originated proposal (IOP) / investigator initiated study/trial (IIS/T) according to AMG and GCP regulations.

Trial Profile

Psoriasis-topoproteome under ustekinumab treatment (PIROUETTE-Study) - as an interventional observation study (phase IV) within approved label and indication and with minimal invasive taking of skin biopsies - as an investigator originated proposal (IOP) / investigator initiated study/trial (IIS/T) according to AMG and GCP regulations.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2013

At a glance

  • Drugs Ustekinumab (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms PIROUETTE
  • Most Recent Events

    • 30 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 25 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top